Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

LENTIVIRAL DENDRITIC CELL VACCINE RAISES PROTECTIVE CTLs AND TARGETS LATENT HIV

By Enthusiast Inc MDFebruary 15, 2017

…that package the lentiviral accessory protein Vpx. Vpx increases DC transduction by two-logs allowing for long-term antigen expression, a significant improvement over peptide-pulsing. To test this approach, we generated vectors…

ACCEPTABILITY AND FEASIBILITY OF A NEW URINE-BASED TENOFOVIR ADHERENCE TEST IN KENYA

By Jimmy He PharmD, DScMarch 3, 2023

…feasible among women taking PrEP and PrEP providers in Kenya Methods: We conducted semi-structured in-depth interviews with 17 women on PrEP who were enrolled in the POC assay arm of…

THE BREADTH AND POLYFUNCTIONALITY OF T CELL RESPONSES TO CMV DIFFER BY HIV STATUS

By Jimmy He PharmD, DScMarch 3, 2023

…antigens would differ by HIV status. Methods: CD4 and CD8 T cell responses to peptide pools spanning 19 CMV open reading frames (ORFs) were measured by intracellular cytokine staining for…

Maturation Inhibitor Mechanistic Studies – Differential Inhibition of Gag Polymorphs

By Enthusiast Inc MDFebruary 27, 2015

…model compound. Understanding the mechanism of action of MIs in greater detail may be of value to help guide the development of MIs with improved genotypic coverage. Methods: In this…

BACTERIAL VAGINOSIS ASSOCIATED MICROBES INDUCE ALTERED INNATE IMMUNE PROFILES

By Enthusiast Inc MDMarch 6, 2018

…women with BV (Nugent >7), and without BV (Nugent <5). We used flow cytometry to assess phenotype and functionality of neutrophils, and performed in vitro whole blood co-cultures with bacteria…

ASSOCIATION OF WEIGHT GAIN ON DOLUTEGRAVIR WITH CHANGES IN ADHERENCE AND VIRAL LOAD

By Jimmy He PharmD, DScMarch 3, 2023

…viral load (VL) among PLWH switching to tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD). Methods: The longitudinal African Cohort Study (AFRICOS) enrolls PLWH engaged in routine care at 12 PEPFAR-supported facilities in Kenya,…

1124 – Opportunities to Improve Mpox Vaccination Coverage Among Transfeminine Persons Across the US

By Jimmy He PharmD, DScMarch 31, 2026

…From February-May 2025 through the Transgender Women’s Internet Survey and Testing (TWIST) study, we recruited transgender women and transfeminine nonbinary persons assigned male at birth (hereafter “tranfems”) in the United…

Resistance Pathways for Potent and Broadly Active HIV-1 Maturation Inhibitors

By Enthusiast Inc MDFebruary 16, 2016

A betulinic acid-based compound, bevirimat (BVM), the first-in-class HIV-1 maturation inhibitor, acts by blocking a late step in protease-mediated Gag processing: the cleavage of the capsid-spacer peptide 1 (CA-SP1) intermediate…

HIV ENV: STRUCTURE, FUNCTION, AND INHIBITION THEREOF

By Enthusiast Inc MDMarch 5, 2018

Like other type 1 fusion machines, the HIV-1 envelope (Env) trimer transitions between prefusion, pre-hairpin intermediate and postfusion conformations to merge viral and host cell membranes during virus entry. In…

862 – Durability of Semaglutide Effects After Drug Discontinuation in HIV-Associated Lipohypertrophy

By Jimmy He PharmD, DScMarch 20, 2025

…phase 2b clinical trial, we observed significant effects of the glucagon-like peptide-1 receptor agonist (GLP-1 RA), semaglutide, over 32 weeks on key outcome measures, including reductions in weight, total body fat,…

←1
2345678910111213141516171819202122232425262728293031323334353637383940414243444546474849505152
…5354555657…
58596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top